We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MBX market cap is 56.05M. The company's latest EPS is CAD 0.0258 and P/E is 15.50.
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 10.53M | 18.59M | 19.08M | 16.52M | 25.39M |
| Operating Income | -3.6M | 4.84M | 2.61M | -2.74M | 3.91M |
| Net Income | -6.23M | 3.23M | 1.79M | -39k | 3.52M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 15.6M | 28.83M | 33.15M | 35.65M | 38.1M |
| Total Liabilities | 8.98M | 10.27M | 8.21M | 11.03M | 9.8M |
| Total Equity | 6.62M | 18.56M | 24.94M | 24.62M | 28.3M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | 9k | 2.11M | 3.47M | -1.1M | 4.35M |
| Investing | -814k | -622k | -2.03M | -1.02M | -1.91M |
| Financing | 802k | 8.41M | 2.06M | 229k | -1.08M |
| Market Cap | 56.05M |
| Price to Earnings Ratio | 15.50 |
| Price to Sales Ratio | 2.15 |
| Price to Cash Ratio | 4.22 |
| Price to Book Ratio | 1.93 |
| Dividend Yield | - |
| Shares Outstanding | 136.7M |
| Average Volume (1 week) | 68.29k |
| Average Volume (1 Month) | 94.55k |
| 52 Week Change | 5.13% |
| 52 Week High | 0.45 |
| 52 Week Low | 0.29 |
| Spread (Intraday) | 0.01 (2.44%) |
| Company Name | Microbix Biosystems Inc |
| Address |
265 watline avenue mississauga, ontario L4Z 1P3 |
| Website | https://www.microbix.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
